Cytoskeletal mechanisms of neuronal degeneration

Cell and Tissue Research

Volumn 305, Issue 2, 2001, Pages 255-265

  Brandt, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Cytoskeleton; Neurofilament; Tau protein

Indexed keywords

NEUROFILAMENT PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CYTOSKELETON; DEGENERATIVE DISEASE; HUMAN; MOTOR NEURON DISEASE; NERVE CELL DEGENERATION; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CYTOSKELETON; HUMANS; NERVE DEGENERATION; TAU PROTEINS;

EID: 0034920481     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004410000334     Document Type: Review

References (111)

1. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
2. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease
3. Structure and novel exons of the human tau gene
4. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine
5. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis
6. Prenatal onset of axonopathy in dystonia musculorum mice
7. 262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding
8. Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration
9. The distribution of tau in the mammalian central nervous system
10. Axonal pathology in myelin disorders
11. Tau is enriched on dynamic microtubules in the distal region of growing axons
12. Neuropathological stageing of Alzheimer-related changes
13. Staging of Alzheimer-related cortical destruction
14. The tau proteins in Alzheimer's disease
15. Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro
16. Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation
17. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain
18. Both adult and juvenile tau microtubule-associated proteins are axon specific in the developing and adult rat cerebellum
19. Transgenic expression of the shortest human tau affect its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease
20. Pathogenesis of amyotrophic lateral sclerosis: A critical review
21. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
22. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons
23. The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons
24. Overexpression of alpha internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice
25. Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis
26. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly
27. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin
28. Microtubule-associated proteins and in vitro astrocyte differentiation
29. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase
30. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation
31. Missense tau mutations in FTDP-17 have a small effect on tau-microtubule interactions
32. Pick's disease: A modern approach
33. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
34. Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H
35. Modulation of the dynamic instability of tubulin assembly by the microtubule associated protein tau
36. Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors
37. Structural and functional implications of tau hyperphosphorylation: Information from phosphorylation-mimicking mutated tau proteins
38. Sense and antisense transfection analysis of tau function - tau influences net microtubule assembly, neurite outgrowth and neuritic stability
39. Pathogenesis of two axonopathies does not require axonal neurofilaments
40. Neurodegenerative disorders with extensive tau pathology: A comparative study and review
41. Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: Evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and tau
42. Neuronal cytoskeletal changes are an early consequence of repetitive head injury
43. Aberrant stress-induced phosphorylation of perikaryal neurofilaments
44. Molecular characterization of microtubule-associated proteins tau and MAP2
45. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
46. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases
47. Phosphoprotein phosphatase activities in Alzheimer disease
48. Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly
49. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform
50. Tau filament formation in transgenic mice expressing P301L tau
51. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau
52. Domains of tau protein and interactions with microtubules
53. Altered microtubule organization in small-calibre axons of mice lacking tau protein
54. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly
55. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
56. Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments
57. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
58. Disruption of the type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits
59. Modulation of tau phosphorylation and intracellular localization by cellular stress
60. Neurofilament functions in health and disease
61. Neurofilaments in health and disease
62. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments
63. Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner
64. Detection of D-aspartate in tau proteins associated with Alzheimer paired helical filaments
65. Ligand-dependent tau filament formation: Implications for Alzheimer's disease progression
66. Antagonistic roles of neurofilament subunits NF-H and NF-M against NF-L in shaping dendritic arborization in spinal motor neurons
67. Developmentally regulated expression of specific tau sequences
68. Analysis of microtubule-associated protein tau glycation in paired helical filaments
69. The microtubule binding domain of tau protein
70. Tau interacts with src-family non-receptor tyrosine kinases
71. Neuronal intermediate filaments
72. Neurotoxicity induces cleavage of p35 to p25 by calpain
73. Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau
74. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
75. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
76. Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein tau
77. Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes
78. Functional studies of Alzheimer's disease tau proteins
79. Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments
80. A spatial gradient of tau protein phosphorylation in nascent axons
81. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
82. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments
83. Proline-directed and non-proline-directed phosphorylation of PHF-tau
84. Apoptosis in neural development and disease
85. Phosphorylation determines two distinct species of Tau in the central nervous system
86. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase
87. Conversion of p35 tp p25 deregulates Cdk5 activity and promotes neurodegeneration
88. The FTDP-17-linked mutation R406 W abolishes the interaction of phosphorylated tau with microtubules
89. Neurotrophins differentially regulate the survival and morphological complexity of human CNS model neurons
90. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells
91. Proliferation, differentiation, and long-term culture of primary hippocampal neurons
92. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis
93. Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination
94. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments
95. Molecular interactions among protein phosphatase 2A, tau, and microtubules
96. Tau protein pathology in neurodegenerative diseases
97. Neurofilament metabolism in sporadic amyotrophic lateral sclerosis
98. Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta
99. Acute inactivation of tau has no effect on dynamics of microtubules in growing axons of cultured sympathetic neurons
100. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS)
101. Altered tau and neurofilament proteins in neurodegenerative diseases: Diagnostic implications for Alzheimer's disease and Lewy body dementia
102. Fatal attraction: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia
103. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions
104. Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly
105. Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organization
106. Molecular aspects of Huntington's disease
107. A protein factor essential for microtubule assembly
108. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
109. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant
110. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments
111. Disruption of the NF-H gene increases axonal microtubule content and velocity of neurofilament transport: Relief of axonopathy resulting from the toxin beta, beta'-iminodipropionitrile